Here’s why Alexion Pharmaceuticals (ALXN) sky-rocketed in the pre-market session

AVGR Stock

Alexion Pharmaceuticals stocks surged 33.09% to $161.1 in the pre-market session following a report that AstraZeneca and Alexion Pharmaceuticals (ALXN) have signed a formal deal about the purchase of Alexion by AstraZeneca. As demonstrated by American Depositary Receipts (ADRs), for each Alexion share, Alexion shareholders would earn $60 in cash and 2,1243 AstraZeneca American Depositary […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.